Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 May 1;145(5):1344-52.
doi: 10.1084/jem.145.5.1344.

Production of the second component of complement by human monocytes: stimulation by antigen-activated lymphocytes or lymphokines

Production of the second component of complement by human monocytes: stimulation by antigen-activated lymphocytes or lymphokines

B H Littman et al. J Exp Med. .

Abstract

Human peripheral blood mononuclear cells cultured in the presence of antigen produced hemolytically active second complement component earlier and in larger amounts than did control cultures of the same cells without antigen. The increased amount of C2 in culture supernates came primarily from the adherent cell population and was due to increased synthesis as demonstrated by inhibition with 10(-4) M cycloheximide. Purified adherent monocytes produced more C2 when exposed to lymphokine-rich supernates from antigen-stimulated lymphocytes than when exposed to control supernates from unstimulated lymphocyte cultures. The increased synthesis of C2, which appeared to be mediated by a lymphokine, was partially inhibited specifically by 0.025 M alpha-L(-) fucose, a sugar which has previously been shown in inhibit the response of macrophages to migration inhibitory factor.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Immunology. 1976 Nov;31(5):781-8 - PubMed
    1. J Immunol. 1972 Oct;109(4):914-7 - PubMed
    1. Fed Proc. 1975 Jul;34(8):1730-6 - PubMed
    1. Cell Immunol. 1974 Feb;10(2):248-59 - PubMed
    1. Cell Immunol. 1976 Jun 15;24(2):241-9 - PubMed

Publication types